Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)

Who May Qualify: - Participants greater than or equal to 50 years of age at time of signing willing to sign a consent form Form - Willing to comply with all study procedures and sign the willing to sign a consent form Form (ICF) - Individuals with normal healthy eyes or diagnosed with any stage of Age-Related Macular Degeneration (treatment naïve patients with early, intermediate, or late AMD). The diagnosis and eligibility review will be confirmed by Central Reading Center. Who Should NOT Join This Trial: - Therapeutic treatment for any type of AMD, in either eye. Supplements, such as AREDS2 formula, are allowed. - Unable to acquire adequate quality images, as evaluated by the Central Reading Center - Severe vision loss requiring urgent surgery - Contraindicated for acquiring retinal images due to narrow anterior chamber angles or hypersensitivity to light - A systemic or ocular condition that in the opinion of the Investigator would preclude participation in the study - Unwilling to sign willing to sign a consent form form - Currently or previously enrolled in an interventional AMD clinical trial Always talk to your doctor about whether this trial is right for you.